Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Columbia's Crinone

May 15, 1997

GH secretagogues disclosed by Merck & Co.

May 14, 1997

Osiris Therapeutics obtains U.S. patent for mesenchymal stem cell gene therapy

May 13, 1997

Osaterone enhances bone formation in ovariectomized rats

May 12, 1997

Effects of L-692429 in obese and nonobese young men

May 12, 1997

Procter & Gamble and Hoechst Marion Roussel to comarket Actonel

May 12, 1997

Prodrugs of calcitriol disclosed by Wisconsin Alumni Research Foundation

May 12, 1997

Selective beta3-agonists from Lilly

May 12, 1997

Lilly discloses selective beta3-agonists

May 9, 1997

Smith & Nephew to evaluate DynaGen's Orthodyn

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...